Clinical Trials Directory

Trials / Completed

CompletedNCT03300596

Brief New Treatment for Suicide Attempts

Suicidal Adults With Alcohol or Drug Use Problems: A New Hospital-based Treatment

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
34 (actual)
Sponsor
University of Rochester · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Individuals with alcohol or drug use problems who are hospitalized for suicide attempt are at high risk for reattempt. This treatment development study adapts a promising outpatient intervention to prevent suicide reattempt in order to administer it during hospitalization to individuals with alcohol and drug use problems, and to test the adapted intervention in a pilot randomized controlled trial.

Conditions

Interventions

TypeNameDescription
BEHAVIORALBrief intervention to prevent suicide attemptA patient-centered, 3-session intervention that calls for videotaping the narrative story of a patient's suicide attempt, in his/her own words (session 1); reviewing segments of the tape to arrive at a shared understanding of the attempt and the sequence of events that led to it (session 2); and using this information, along with a homework task completed by the patient in-between sessions, in order to develop a collaborative, comprehensive written safety plan that addresses the patient's unique vulnerabilities (session 3).
BEHAVIORALEnhanced treatment as usualSafety procedures' control intervention. For these procedures we will share summary results of the research assessments regarding suicidal thoughts, suicidal behaviors, alcohol and drug use and related problems, and depressive symptoms with appropriate hospital clinical staff. We will also arrange to send this information, with participants' permission, to their ongoing therapist or treatment program and, if none exists, to the therapist or program to which they are being referred. In this regard, the research assessment protocol serves a dual function of helping with additional monitoring of high-risk patients in addition to providing data for the study.

Timeline

Start date
2018-03-12
Primary completion
2020-09-15
Completion
2020-09-15
First posted
2017-10-03
Last updated
2020-09-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03300596. Inclusion in this directory is not an endorsement.